Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.56 |
| ▸ | GLA | P06280 | 5/20 | 0.56 |
| ▸ | HPGD | P15428 | 4/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | MAOA | P21397 | 2/20 | 0.56 |
| ▸ | CASP1 | P29466 | 2/20 | 0.56 |
| ▸ | CASP7 | P55210 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | ACHE | P22303 | 2/20 | 0.56 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.56 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.56 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.56 |
| ▸ | NQO2 | P16083 | 1/20 | 0.56 |
| ▸ | DRD1 | P21728 | 1/20 | 0.56 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5908336 | 0.83 | KMT2A (0.45) | ALDH1A1KDM4EGLAHPGDSMN1; SMN2 | |
| SCHEMBL3966414 | 0.77 | GPR3 (0.57) | ALDH1A1KDM4EHPGDHSD17B10MAPT | |
| SCHEMBL1502392 | 0.77 | ALDH1A1 (0.62) | ALDH1A1KDM4EGLAHPGDSMN1; SMN2 | |
| SCHEMBL2522239 | 0.75 | ALDH1A1 (0.41) | ALDH1A1KDM4EHPGDSMN1; SMN2HSD17B10 | |
| SCHEMBL13400206 | 0.74 | ALDH1A1 (0.59) | ALDH1A1KDM4EGLAHPGDSMN1; SMN2 | |
| SCHEMBL6784629 | 0.74 | ERN1 (0.57) | ALDH1A1KDM4EHPGDSMN1; SMN2HSD17B10 | |
| SCHEMBL1386112 | 0.74 | GPR3 (0.54) | ALDH1A1KDM4EGLAHPGDSMN1; SMN2 | |
| SCHEMBL23172252 | 0.72 | KDM4E (0.56) | ALDH1A1KDM4EGLAHPGDSMN1; SMN2 | |
| SCHEMBL4894495 | 0.72 | KDM4E (0.56) | ALDH1A1KDM4EGLAHPGDSMN1; SMN2 | |
| SCHEMBL17423367 | 0.72 | KDM4E (0.56) | ALDH1A1KDM4EGLAHPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8481696-B2 | Glycosylated glycopeptide antibiotic derivatives | SHIONOGI & CO., LTD. (JP) | 2013-07-09 | — | — | US | disclosed |
| US-20100286364-A1 | GLYCOSYLATED GLYCOPEPTIDE ANTIBIOTIC DERIVATIVES | SHIONOGI & CO., LTD. (JP) | 2010-11-11 | — | — | US | disclosed |
| US-7825146-B2 | Sulfonamide derivative having isoxazole ring | SHIONOGI & CO., LTD. (JP) | 2010-11-02 | — | — | US | disclosed |
| EP-2233495-A1 | GLYCOSYLATED GLYCOPEPTIDE ANTIBIOTIC DERIVATIVE | Shionogi & Co., Ltd. (JP) | 2010-09-29 | — | — | EP | disclosed |
| US-20100099676-A1 | SULFONYLUREA DERIVATIVE CAPABLE OF SELECTIVELY INHIBITING MMP-13 | SHIONOGI & CO., LTD. (JP) | 2010-04-22 | — | — | US | disclosed |
| EP-2128134-A1 | SULFONYLUREA DERIVATIVE CAPABLE OF SELECTIVELY INHIBITING MMP-13 | Shionogi&Co., Ltd. (JP) | 2009-12-02 | — | — | EP | disclosed |
| US-20090069304-A1 | MMP-13 SELECTIVE INHIBITOR | SHIONOGI & CO., LTD. (JP) | 2009-03-12 | — | — | US | disclosed |
| EP-1997804-A1 | MMP-13-SELECTIVE INHIBITOR | SHIONOGI & CO., LTD. (JP) | 2008-12-03 | — | — | EP | disclosed |
| US-20080119513-A1 | Sulfonamide Derivative Selectively Inhibiting Mmp-13 | SHIONOGI & CO., LTD. (JP) | 2008-05-22 | — | — | US | disclosed |
| EP-1787979-A1 | SULFONAMIDE DERIVATIVE SELECTIVELY INHIBITING MMP-13 | Shionogi Co., Ltd. (JP) | 2007-05-23 | — | — | EP | disclosed |
| EP-1277744-A1 | OXADIAZOLE DERIVATIVES HAVING ANTICANCER EFFECTS | SHIONOGI & CO., LTD. (JP) | 2003-01-22 | — | — | EP | disclosed |
| US-6495578-B1 | SULFONAAMIDE DERIVATIVES CONTAINING OXADIZOLE RING AND A GROUP SELECTED FROM CARBOXY, ACYLOXYALKYL OR AMIDOHYDROXY GROUP; HAVING A MATRIX METALLOPROTEASE INHIBITING EFFECT; ANTICARCINOGENIC AGENT | SHIONOGI & CO., LTD. (JP) | 2002-12-17 | — | — | US | disclosed |
| US-6441021-B1 | TYPE-IV COLLAGENASE INHIBITORS | SHIONOGI & CO., LTD. (JP) | 2002-08-27 | — | — | US | disclosed |
| US-6423729-B1 | KIDNEY DISORDERS | SHIONOGI & CO., LTD. (JP) | 2002-07-23 | — | — | US | disclosed |
| EP-1172361-A1 | SULFONAMIDE DERIVATIVES HAVING OXADIAZOLE RINGS | SHIONOGI & CO., LTD. (JP) | 2002-01-16 | — | — | EP | disclosed |
| US-6235768-B1 | OSTEOPOROSIS; RHEUMATIC DISORDERS; ANTITUMOR AGENTS | SHIONOGI & CO., LTD. (JP) | 2001-05-22 | — | — | US | disclosed |
| US-6207698-B1 | FOR THERAPY OF OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, CORNEAL ULCERATION, PERIODONTITIS, METASTASIS AND INVASION OF TUMOR, AND VIRUS INFECTION | SHIONOGI & CO., LTD. (JP) | 2001-03-27 | — | — | US | disclosed |
| US-6150394-A | 1-(INDOLYL),1-((PHENYL)PHENYL)SULFONAMIDO)ACETIC ACID OR N-HYDROXYACETAMIDE AND DERIVATIVES; ENZYME INHIBITORS E.G., GELATINASE, STROMELYSIN, COLLAGENASE; OSTEOARTHRITIS, RHEUMATOID ARTHRITIS, CORNEAL ULCERATION, PERIODONTITIS, HIV | SHIONOGI & CO., LTD. (JP) | 2000-11-21 | — | — | US | disclosed |
| EP-1029541-A1 | THERAPEUTIC OR PROPHYLACTIC AGENT FOR GLOMERULOPATHY | SHIONOGI & CO., LTD. (JP) | 2000-08-23 | — | — | EP | disclosed |
| EP-0950656-A1 | SULFONATED AMINO ACID DERIVATIVES AND METALLOPROTEINASE INHIBITORS CONTAINING THE SAME | SHIONOGI & CO., LTD. (JP) | 1999-10-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090069304-A1 | MMP-13 SELECTIVE INHIBITOR | MMP13, MMP11, MMP3 | ALDH1A1 776/4885KDM4E 1116/4885GLA 442/4885 |
| US-20080119513-A1 | Sulfonamide Derivative Selectively Inhibiting Mmp-13 | MMP13, MMP3, MMP11 | ALDH1A1 365/4885KDM4E 1419/4885GLA 143/4885 |
| US-20100099676-A1 | SULFONYLUREA DERIVATIVE CAPABLE OF SELECTIVELY INHIBITING MMP-13 | MMP13, MMP3, MMP26 | ALDH1A1 469/4885KDM4E 1419/4885GLA 643/4885 |
| US-20100286364-A1 | GLYCOSYLATED GLYCOPEPTIDE ANTIBIOTIC DERIVATIVES | CSGALNACT1, OGT, GALNT1 | ALDH1A1 724/4885KDM4E 2334/4885GLA 323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.